The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism

D. B. Ambrus*, J. I. Reisman, A. J. Rose

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science